Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 1/20 | 0.47 |
| ▸ | HTR1A | P08908 | 10/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 6/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 6/20 | 0.46 |
| ▸ | HTR7 | P34969 | 3/20 | 0.42 |
| ▸ | HTR6 | P50406 | 5/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.40 |
| ▸ | HTR2B | P41595 | 2/20 | 0.40 |
| ▸ | HTR3A | P46098 | 2/20 | 0.39 |
| ▸ | HTR1D | P28221 | 1/20 | 0.39 |
| ▸ | HTR1B | P28222 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6027239 | 0.88 | KDR (0.47) | KDRHTR1ASLC6A2SLC6A4HTR7 | |
| SCHEMBL24760628 | 0.80 | HTR1A (0.49) | KDRHTR1ASLC6A2SLC6A4HTR7 | |
| SCHEMBL27474954 | 0.80 | HTR1A (0.49) | KDRHTR1ASLC6A2SLC6A4HTR7 | |
| SCHEMBL28775480 | 0.79 | KDR (0.47) | KDRHTR1ASLC6A2SLC6A4HTR7 | |
| Hydrochloric Acid SCHEMBL27621259 | 0.79 | HTR1A (0.48) | KDRHTR1ASLC6A2SLC6A4HTR7 | |
| SCHEMBL5023862 | 0.78 | ALDH1A1 (0.45) | KDRHTR1ASLC6A2SLC6A4HTR6 | |
| Tert-Butyl Formate SCHEMBL27621184 | 0.76 | HTR1A (0.41) | KDRHTR1ASLC6A2SLC6A4HTR6 | |
| Hydrochloric Acid SCHEMBL5913628 | 0.76 | KDR (0.49) | KDRHTR1ASLC6A2SLC6A4HTR7 | |
| SCHEMBL13862081 | 0.74 | CHRNB2 (0.46) | HTR1ASLC6A2SLC6A4HTR7SLC6A3 | |
| SCHEMBL233938 | 0.74 | KDR (0.53) | KDRHTR1ASLC6A2SLC6A4HTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1833800-A1 | PYRAZOLONE COMPOUNDS AS METABOTROPIC GLUTAMATE RECEPTOR AGONISTS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS | AstraZeneca AB (SE) | 2007-09-19 | — | — | EP | disclosed |
| WO-2006071730-A1 | PYRAZOLONE COMPOUNDS AS METABOTROPIC GLUTAMATE RECEPTOR AGONISTS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS | ASTRAZENECA AB (SE) | 2006-07-06 | — | — | WO | disclosed |